Lassie Lassie: The first-ever painless breath analyser for people with diabetes, a breakthrough in blood glucose monitoring

Summary

Today, dogs are used to detect high and low blood glucose, cancers and are tested for coronavirus.
The new Lassie breath analyser BOYDSense will put the power of a dog’s nose into people’s hands and give them access to gentle health monitoring.
Lassie starts with diabetes as it is an immense burden for 40 million people in Europe. Current glucose monitoring technologies are underused because they are highly invasive, expensive, stigmatising and generate a lot of waste.
Lassie will transform this situation by making measurements painless, simple, discreet and cost-effective without any consumables. By analysing Volatile Organic Compounds (VOCs) in the breath, Lassie will calculate blood glucose value within current accuracy standard. As a result, Lassie users will test earlier in the disease and more frequently, leading to better diabetes management and significant cost savings. EIC Accelerator will put BOYDSense on track to become a global leader in non-invasive diabetes monitoring.

Resources

Show all and search (1)

Unfold all

Fold all

More information & hyperlinks

Web resources:	https://cordis.europa.eu/project/id/190162033
Start date:	01-08-2022
End date:	31-01-2025
Total budget - Public funding:	10 846 250,00 Euro - 2 500 000,00 Euro

Cordis data

Original description

Today, dogs are used to detect high and low blood glucose, cancers and are tested for coronavirus.
The new Lassie breath analyser BOYDSense will put the power of a dogs nose into peoples hands and give them access to gentle health monitoring.
Lassie starts with diabetes as it is an immense burden for 40 million people in Europe. Current glucose monitoring technologies are underused because they are highly invasive, expensive, stigmatising and generate a lot of waste.
Lassie will transform this situation by making measurements painless, simple, discreet and cost-effective without any consumables. By analysing Volatile Organic Compounds (VOCs) in the breath, Lassie will calculate blood glucose value within current accuracy standard. As a result, Lassie users will test earlier in the disease and more frequently, leading to better diabetes management and significant cost savings. EIC Accelerator will put BOYDSense on track to become a global leader in non-invasive diabetes monitoring.